Coronavirus vaccine trial halted after volunteer develops illness

Drug maker AstraZeneca’s vaccine candidate has been considered one of the most promising, but its Phase 3 trial is now on hold after a volunteer developed symptoms consistent with transverse myelitis, a serious inflammation of the spinal cord.